SCHEMBL29979732

SCHEMBL29979732

Cc1ccc2nc(CO)n(COCC[Si](C)(C)C)c2c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
TNF P01375 1/20 0.44
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KCNH2 Q12809 1/20 0.37
TLR8 Q9NR97 1/20 0.37
ACSS2 Q9NR19 1/20 0.37
NPC1 O15118 2/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
TP53 P04637 1/20 0.36
NPSR1 Q6W5P4 2/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29117187 1.00 TSHR (0.44) TSHRTNFRAB9ASMN1; SMN2MEN1
SCHEMBL19857729 0.90 TSHR (0.44) TSHRTNFRAB9ASMN1; SMN2MEN1
SCHEMBL29979676 0.88 TLR8 (0.40) TSHRTNFRAB9ASMN1; SMN2KCNH2
SCHEMBL2655223 0.83 SMN1; SMN2 (0.52) TSHRTNFRAB9ASMN1; SMN2MEN1
SCHEMBL31667365 0.82 KCNH2 (0.39) RAB9AMEN1KMT2AKCNH2TLR8
SCHEMBL29980097 0.82 CYP1A2 (0.41) TSHRRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31667604 0.81 MTNR1A (0.40) TSHRRAB9ASMN1; SMN2KCNH2TLR8
SCHEMBL29117268 0.80 IKBKB (0.38) MEN1KMT2AKCNH2TLR8ACSS2
SCHEMBL637860 0.79 BRD4 (0.39) TNFRAB9ANPC1
SCHEMBL13273918 0.77 ALDH1A1 (0.54) TSHRTNFRAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4284365-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2023-12-06 EP disclosed
CN-117177744-A CDK2 inhibitors and methods of use thereof 塞迪拉治疗股份有限公司 2023-12-05 CN disclosed
WO-2022165513-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2022-08-04 WO disclosed